<DOC>
	<DOCNO>NCT00002360</DOCNO>
	<brief_summary>The purpose study see coated-capsule form didanosine ( ddI ) safe absorb body well chewable-tablet form ddI . Didanosine ( ddI ) anti-HIV drug . The effectiveness ddI lower acid stomach . To prevent , patient take antacid ddI . The coated-capsule form ddI may replace need antacid .</brief_summary>
	<brief_title>A Study Comparing Two Forms Didanosine HIV-infected Patients</brief_title>
	<detailed_description>Didanosine , purine nucleoside analogue , indicate treatment HIV infection antiretroviral therapy warrant . Didanosine administer orally antacids protect acid-induced hydrolysis stomach . To eliminate need use buffer ddI formulation , enteric-coated bead formulation ddI develop . Patients randomize 1 2 group receive treatment 2 separate occasion least 72 hour apart . Group 1 receive reference formulation ddI . Group 2 receive test formulation ddI . Clinical evaluation , include clinical laboratory test , perform periodically study discharge . Serial blood sample collect specific time point 12 hour follow dosing , use pharmacokinetic variable CMAX AUC ( INF ) . Factors use analysis sequence , subject within sequence , period , formulation . Safety assess monitor adverse effect , vital sign , ECG recording , clinical laboratory test throughout study .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . CD4 cell count least 200 cells/mm3 . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Any evidence organ dysfunction . Any clinically significant deviation specify baseline requirement physical examination , laboratory test , 12lead electrocardiogram .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Didanosine</keyword>
	<keyword>Tablets</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Therapeutic Equivalency</keyword>
</DOC>